Dr. Manchikanti believes that with the proper measures in place to reduce improper drug distribution, many cases of substance abuse could be prevented. In a 2009 interview with Pain Medicine News, he talked about a bill introduced by Sen. John Rockefeller focused on reducing methadone-related deaths. If the bill can be expanded to cover more prescription drugs, he said “these measures will reduce abuse. The people who need these drugs will get them, at reasonable doses and with proper monitoring.”
Dr. Manchikanti graduated from Gandhi Medical College at Osmania University Hyderabad, India, and completed his internship and residency in anesthesiology at Gandhi Hospital in Hyderabad, India, Youngstown (Ohio) Hospital and Allegheny General Hospital in Pennsylvania. He also completed a fellowship in anesthesiology and critical care medicine at the University of Pittsburgh.
As the CEO and chairman of the board of the American Society of Interventional Pain Physicians, Dr. Manchikanti is invested in preserving the financial solvency of interventional pain management practices.
He wrote in the fall 2007 issue of ASIPP News that “just as evidence must be employed to avoid harmful errors of omission and commission, we must heed evidence that inattention to the administrative priorities of health care regulation can be equally harmful, refute the ethical goods of medicine, and are contrary to the public service of policy and government.”
Read Dr. Manchikanti’s thoughts on current trends in interventional pain management.
Read about Dr. Manchikanti and 71 other physician leaders on Becker’s list of “72 Physician Leaders in the ASC Industry”.
